Correlation of macroscopic and microscopic pathology in risk reducing salpingo-oophorectomy: Implications for intraoperative specimen evaluation

被引:9
|
作者
Rabban, Joseph T. [1 ]
Mackey, Amber [1 ]
Powell, C. Bethan [2 ]
Crawford, Beth [3 ]
Zaloudek, Charles J. [1 ]
Chen, Lee-may [2 ]
机构
[1] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94313 USA
[2] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94313 USA
[3] UCSF Helen Diller Family Comprehens Canc Ctr, Canc Risk Program, San Francisco, CA USA
关键词
Risk-reducing salpingo-oophorectomy; Intraoperative evaluation; Occult carcinoma; BRCA; Fallopian tube; FALLOPIAN-TUBE; PROPHYLACTIC OOPHORECTOMY; MUTATION CARRIERS; FROZEN-SECTION; FORMALIN FIXATION; BRCA MUTATIONS; OVARIAN-TUMORS; BREAST-CANCER; WOMEN; CARCINOMA;
D O I
10.1016/j.ygyno.2011.01.031
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. A minority of risk-reducing salpingo-oophorectomy (RRSO) specimens from BRCA mutation carriers will contain clinically occult carcinoma that is detectable only using a specialized pathologic evaluation protocol. Although intraoperative detection of cancer may alter immediate surgical management, technical complications impairing pathologic diagnosis may result if fresh tissue dissection and frozen sections are performed on unselected RRSO specimens. We hypothesize that macroscopic specimen findings may predict which RRSO specimens contain cancer and therefore may guide selection of specimens for intraoperative pathologic evaluation. The aim of this study was to correlate the macroscopic and microscopic pathologic findings in RRSO. Methods. RRSO specimens from 134 women with a BRCA mutation were retrospectively classified by their grossly visible findings (cysts and/or nodules versus grossly unremarkable). Correlation of the gross findings with the microscopic finding of occult tubal and/or ovarian carcinoma was performed by re-examination of all pathology slides. Results. While 46% of RRSO had visible ovarian cysts and 34% had visible tubal/paratubal cysts, no cyst contained cancer on microscopic examination. Carcinoma was detected in 2/22 (9%) visible ovarian nodules and in 2/8 (25%) visible tubal nodules. Conversely, among all 11 RRSO specimens containing cancer, 7 (64%) had no corresponding visible abnormality. Conclusion. Frozen section evaluation of a solid nodule may be valuable in patients consented for immediate surgical staging. Otherwise it is best to avoid intraoperative dissection or frozen section of RRSO that are macroscopically normal or contain only cysts; such specimens should remain undissected for immediate formalin-fixation as the first step of the specialized pathology evaluation protocol. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:466 / 471
页数:6
相关论文
共 50 条
  • [31] Risk-reducing bilateral salpingo-oophorectomy: For whom, how and what results?
    Favier, Amelia
    Evrevin, Clemence
    Desseignes, Camille
    Benusiglio, Patrick R.
    Uzan, Catherine
    BULLETIN DU CANCER, 2025, 112 (03) : 307 - 315
  • [32] Prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers: what is going on in a region of northern Italy?
    Grandi, Giovanni
    Perrone, Anna Myriam
    Perrone, Antonino
    Mandato, Vincenzo Dario
    Comerci, Giuseppe
    Sammarini, Margaret
    Merisio, Carla
    Amadori, Andrea
    Stefanetti, Marco
    Martinello, Ruby
    Facchinetti, Fabio
    De Iaco, Pierandrea
    MATURITAS, 2021, 143 : 59 - 64
  • [33] Risk-reducing bilateral salpingo-oophorectomy in women with BRCAI or BRCA2 mutations
    Eleje, George U.
    Eke, AhizechukwuC
    Ezebialu, Ifeanyichukwu U.
    Ikechebelu, Joseph I.
    Ugwu, Emmanuel O.
    Okonkwo, Onyinye O.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (08):
  • [34] Safety of hormone replacement therapy following risk-reducing salpingo-oophorectomy: systematic review of literature and guidelines
    Vermeulen, R. F. M.
    Korse, C. M.
    Kenter, G. G.
    Brood-van Zanten, M. M. A.
    van Beurden, M.
    CLIMACTERIC, 2019, 22 (04) : 352 - 360
  • [35] Efficacy of risk-reducing salpingo-oophorectomy in BRCA1-2 variants and clinical outcomes of follow-up in patients with isolated serous tubal intraepithelial carcinoma (STIC)
    Saccardi, Carlo
    Zovato, Stefania
    Spagnol, Giulia
    Bonaldo, Giulio
    Marchetti, Matteo
    Alessandrini, Lara
    Tognazzo, Silvia
    Guerriero, Angela
    Vitagliano, Amerigo
    Lagana, Antonio Simone
    Noventa, Marco
    GYNECOLOGIC ONCOLOGY, 2021, 163 (02) : 364 - 370
  • [36] Risk-Reducing Salpingo-Oophorectomy (RRSO) in BRCA Mutation Carriers Experience With a Consecutive Series of 111 Patients Using a Standardized Surgical-Pathological Protocol
    Powell, C. Bethan
    Chen, Lee-may
    McLennan, Jane
    Crawford, Beth
    Zaloudek, Charles
    Rabban, Joseph T.
    Moore, Dan H.
    Ziegler, John
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (05) : 846 - 851
  • [37] Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers
    Domchek, Susan M.
    Friebel, Tara M.
    Garber, Judy E.
    Isaacs, Claudine
    Matloff, Ellen
    Eeles, Rosalind
    Evans, D. Gareth
    Rubinstein, Wendy
    Singer, Christian F.
    Rubin, Stephen
    Lynch, Henry T.
    Daly, Mary B.
    Weitzel, Jeffrey
    Ganz, Patricia A.
    Pichert, Gabriella
    Olopade, Olufunmilayo I.
    Tomlinson, Gail
    Tung, Nadine
    Blum, Joanne L.
    Couch, Fergus
    Rebbeck, Timothy R.
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 124 (01) : 195 - 203
  • [38] Understanding the Needs of Women Considering Risk-Reducing Salpingo-oophorectomy
    Cherry, Carol
    Ropka, Mary
    Lyle, Jennifer
    Napolitano, Laura
    Daly, Mary B.
    CANCER NURSING, 2013, 36 (03) : E33 - E38
  • [39] Cost effectiveness of bilateral risk-reducing mastectomy and salpingo-oophorectomy
    Michael G. Schrauder
    Lisa Brunel-Geuder
    Lothar Häberle
    Marius Wunderle
    Juliane Hoyer
    Roland Csorba
    André Reis
    Rüdiger Schulz-Wendtland
    Matthias W. Beckmann
    Michael P. Lux
    European Journal of Medical Research, 24
  • [40] Osteoporosis risk and management in BRCA1 and BRCA2 carriers who undergo risk-reducing salpingo-oophorectomy
    Garcia, Christine
    Lyon, Liisa
    Conell, Carol
    Littell, Ramey D.
    Powell, C. Bethan
    GYNECOLOGIC ONCOLOGY, 2015, 138 (03) : 723 - 726